EPIS B Stock Overview
A medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Episurf Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.12 |
| 52 Week High | SEK 0.77 |
| 52 Week Low | SEK 0.096 |
| Beta | 1.17 |
| 1 Month Change | -4.36% |
| 3 Month Change | -4.06% |
| 1 Year Change | -82.56% |
| 3 Year Change | -95.82% |
| 5 Year Change | -90.52% |
| Change since IPO | -99.56% |
Recent News & Updates
Recent updates
Shareholders May Not Be So Generous With Episurf Medical AB (publ)'s (STO:EPIS B) CEO Compensation And Here's Why
Apr 04
Shareholders May Be More Conservative With Episurf Medical AB (publ)'s (STO:EPIS B) CEO Compensation For Now
Apr 03Here's Why Episurf Medical (STO:EPIS B) Must Use Its Cash Wisely
Feb 27Is Episurf Medical (STO:EPIS B) In A Good Position To Invest In Growth?
Nov 09Will Episurf Medical (STO:EPIS B) Spend Its Cash Wisely?
May 03We're Not Very Worried About Episurf Medical's (STO:EPIS B) Cash Burn Rate
Sep 23Shareholder Returns
| EPIS B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 20.2% | 1.4% | 3.0% |
| 1Y | -82.6% | -19.7% | -9.3% |
Return vs Industry: EPIS B underperformed the Swedish Medical Equipment industry which returned -19.7% over the past year.
Return vs Market: EPIS B underperformed the Swedish Market which returned -9.3% over the past year.
Price Volatility
| EPIS B volatility | |
|---|---|
| EPIS B Average Weekly Movement | 9.2% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in SE Market | 13.7% |
| 10% least volatile stocks in SE Market | 4.1% |
Stable Share Price: EPIS B's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: EPIS B's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 27 | Pal Ryfors | episurf.com |
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also provides Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning.
Episurf Medical AB (publ) Fundamentals Summary
| EPIS B fundamental statistics | |
|---|---|
| Market cap | SEK 84.25m |
| Earnings (TTM) | -SEK 72.10m |
| Revenue (TTM) | SEK 23.00m |
3.5x
P/S Ratio-1.1x
P/E RatioIs EPIS B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EPIS B income statement (TTM) | |
|---|---|
| Revenue | SEK 23.00m |
| Cost of Revenue | SEK 49.80m |
| Gross Profit | -SEK 26.80m |
| Other Expenses | SEK 45.30m |
| Earnings | -SEK 72.10m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
May 05, 2025
| Earnings per share (EPS) | -0.11 |
| Gross Margin | -116.52% |
| Net Profit Margin | -313.48% |
| Debt/Equity Ratio | 0% |
How did EPIS B perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/14 17:31 |
| End of Day Share Price | 2025/04/14 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Episurf Medical AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yilmaz Mahshid | Pareto Securities |
| Anders Hedlund | Redeye |
| John Westborg | Redeye |